Futura Medical (LON:FUM) Trading Down 11.7% – Here’s What Happened

Futura Medical plc (LON:FUM)’s stock price dropped 11.7% during mid-day trading on Wednesday . The stock traded as low as GBX 0.53 and last traded at GBX 0.53. Approximately 3,180,240 shares changed hands during trading, a decline of 48% from the average daily volume of 6,068,521 shares. The stock had previously closed at GBX 0.60.

Futura Medical Trading Down 11.7%

The company has a 50 day moving average price of GBX 0.87 and a 200 day moving average price of GBX 1.09. The company has a market capitalization of £3.08 million, a price-to-earnings ratio of -0.19 and a beta of 0.01.

Futura Medical (LON:FUM) last issued its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. The firm had revenue of GBX 170 million for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. Equities analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.